Related references
Note: Only part of the references are listed.Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors
Joao Leonardo Silveira Rossi et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2022)
Sex-specific contribution of lipid accumulation product and cardiometabolic index in the identification of nonalcoholic fatty liver disease among Chinese adults
Yiting Liu et al.
LIPIDS IN HEALTH AND DISEASE (2022)
Protective Effects of Curcumin in Cardiovascular Diseases-Impact on Oxidative Stress and Mitochondria
Fiona Frederike Cox et al.
CELLS (2022)
NAFLD and cardiovascular diseases: a clinical review
Philipp Kasper et al.
CLINICAL RESEARCH IN CARDIOLOGY (2021)
Atherogenic Index of Plasma Is an Independent Risk Factor for Coronary Artery Disease and a Higher SYNTAX Score
Luzhao Wang et al.
ANGIOLOGY (2021)
Lipoprotein(a): a genetic marker for cardiovascular disease and target for emerging therapies
Arturo Cesaro et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2021)
Non-alcoholic fatty liver disease: Current therapeutic options
Avik Majumdar et al.
CURRENT OPINION IN PHARMACOLOGY (2021)
The Triglyceride-Glucose Index, an Insulin Resistance Marker, Was Non-linear Associated With All-Cause and Cardiovascular Mortality in the General Population
Xiao-cong Liu et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Metabolic and Hepatic Effects of Energy-Reduced Anti-Inflammatory Diet in Younger Adults with Obesity
Gordana Kendel Jovanovic et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis-Systematic Review and Meta-Analysis
Abdulrahman Ismaiel et al.
BIOMEDICINES (2021)
Waist-to-height ratio and non-alcoholic fatty liver disease in adults
Guotai Sheng et al.
BMC GASTROENTEROLOGY (2021)
Curcumin as a Natural Remedy for Atherosclerosis: A Pharmacological Review
Laxman Singh et al.
MOLECULES (2021)
The Effects of Nano-Curcumin Supplementation on Risk Factors for Cardiovascular Disease: A GRADE-Assessed Systematic Review and Meta-Analysis of Clinical Trials
Damoon Ashtary-Larky et al.
ANTIOXIDANTS (2021)
Metabolic Score for Visceral Fat (METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic health
Omar Yaxmehen Bello-Chavolla et al.
CLINICAL NUTRITION (2020)
Epidemiology of chronic liver diseases in the USA in the past three decades
Zobair M. Younossi et al.
GUT (2020)
The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China
Zheng Qin et al.
CARDIOVASCULAR DIABETOLOGY (2020)
The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials
Mohammad Jalali et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2020)
Effects of curcuminoids on inflammatory status in patients with nonalcoholic fatty liver disease: A randomized controlled trial
Maryam Saberi-Karimian et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2020)
Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease
Ze Chen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2020)
Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis
Srinivasan Dasarathy et al.
CONTEMPORARY CLINICAL TRIALS (2020)
Anti-inflammatory effects of phenolic acids punicalagin and curcumin in human placenta and adipose tissue
Caitlyn Nguyen-Ngo et al.
PLACENTA (2020)
Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990–2017: a population-based observational study
Xiaojun Ge et al.
BMJ Open (2020)
Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD)
David Carneros et al.
NUTRIENTS (2020)
Development of a simple nonalcoholic fatty liver disease scoring system indicative of metabolic risks and insulin resistance
Seogsong Jeong et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Effect of lifestyle modification education based on health belief model in overweight/obese patients with non-alcoholic fatty liver disease: A parallel randomized controlled clinical trial
Mojgan Nourian et al.
CLINICAL NUTRITION ESPEN (2020)
Epidemiology of non-alcoholic and alcoholic fatty liver diseases
Souveek Mitra et al.
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with nonalcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial
Seyed Ali Jazayeri-Tehrani et al.
NUTRITION & METABOLISM (2019)
Impact of lipoprotein(a) levels on recurrent cardiovascular events in patients with premature coronary artery disease
Felice Gragnano et al.
INTERNAL AND EMERGENCY MEDICINE (2019)
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
Saeede Saadati et al.
BMC GASTROENTEROLOGY (2019)
Effect of Phytosomal Curcumin on Circulating Levels of Adiponectin and Leptin in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Seyed Reza Mirhafez et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2019)
P5330Evaluating lipid-lowering and anti-atherogenic effect of injectable curcumin in a rabbit model of atherosclerosis
A A Momtazi-Borojeni et al.
EUROPEAN HEART JOURNAL (2019)
Usefullnes of atherogenic indices and Ca-LDL level to predict subclinical atherosclerosis in patients with psoriatic arthritis?
Duygu Tecer et al.
ADVANCES IN RHEUMATOLOGY (2019)
A pilot study of the effect of phospholipid curcumin on serum metabolomic profile in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial
Saeed Chashmniam et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2019)
The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease
Saeede Saadati et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2019)
The effects of curcumin-containing supplements on biomarkers of inflammation and oxidative stress: A systematic review and meta-analysis of randomized controlled trials
Reza Tabrizi et al.
PHYTOTHERAPY RESEARCH (2019)
Fasting triglycerides and glucose index is more suitable for the identification of metabolically unhealthy individuals in the Chinese adult population: A nationwide study
Xinwen Yu et al.
JOURNAL OF DIABETES INVESTIGATION (2019)
The anti-inflammatory potential of diet and nonalcoholic fatty liver disease: the ATTICA study
Stefanos Tyrovolas et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2019)
Multiple Testing and Protection Against a Type 1 (False Positive) Error Using the Bonferroni and Hochberg Corrections
Chittaranjan Andrade
INDIAN JOURNAL OF PSYCHOLOGY MEDICINE (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Validity of triglyceride-glucose index as an indicator for metabolic syndrome in children and adolescents: the CASPIAN-V study
Pooneh Angoorani et al.
EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY (2018)
Fatty liver index is associated to pulse wave velocity in healthy subjects: Data from the Brisighella Heart Study
Arrigo F. G. Cicero et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
The TyG Index as a Marker of Subclinical Atherosclerosis and Arterial Stiffness in Lean and Overweight Postmenopausal Women
Irene Lambrinoudaki et al.
HEART LUNG AND CIRCULATION (2018)
Curcumin or combined curcuminoids are effective in lowering the fasting blood glucose concentrations of individuals with dysglycemia: Systematic review and meta-analysis of randomized controlled trials
Ingrid Sofia Vieira de Melo et al.
PHARMACOLOGICAL RESEARCH (2018)
Validity of the Body Adiposity Index in Predicting Body Fat in Adults: A Systematic Review
Matheus Santos Cerqueira et al.
ADVANCES IN NUTRITION (2018)
Atherogenic index of plasma is a novel predictor of non-alcoholic fatty liver disease in obese participants: a cross-sectional study
Qian Wang et al.
LIPIDS IN HEALTH AND DISEASE (2018)
Atherosclerotic vascular disease and its correlates in stable black South African kidney transplant recipients
Stephen Olawale Oguntola et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE (2018)
The atherogenic index of plasma is a strong and independent predictor for coronary artery disease in the Chinese Han population
Gaojun Cai et al.
MEDICINE (2017)
Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials
Si Qin et al.
NUTRITION JOURNAL (2017)
Differential Impact of Weight Loss on Nonalcoholic Fatty Liver Resolution in a North American Cohort with Obesity
Vikrant Rachakonda et al.
OBESITY (2017)
NAFLD and Atherosclerosis Are Prevented by a Natural Dietary Supplement Containing Curcumin, Silymarin, Guggul, Chlorogenic Acid and Inulin in Mice Fed a High-Fat Diet
Antonella Amato et al.
NUTRIENTS (2017)
Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: A systematic review and meta-analysis
Toufik Mahfood Haddad et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2017)
Lipid accumulation product and metabolic syndrome: a population-based study in northern Iran, Amol
N. Motamed et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2016)
Lipid Accumulation Product and Hypertension Related to Stroke: a 9.2-Year Prospective Study Among Mongolians in China
Chongke Zhong et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2016)
Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial
Sepideh Rahmani et al.
PHYTOTHERAPY RESEARCH (2016)
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
Amedeo Lonardo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance
Kuen Cheh Yang et al.
SCIENTIFIC REPORTS (2016)
Evaluation of dyslipidemia, lipid ratios, and atherogenic index as cardiovascular risk factors among semi-urban dwellers in Nigeria
Michael Adeyemi Olamoyegun et al.
ANNALS OF AFRICAN MEDICINE (2016)
Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease
Jun Luo et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2015)
NAFLD: A multisystem disease
Christopher D. Byrne et al.
JOURNAL OF HEPATOLOGY (2015)
Effect of aerobic exercise training dose on liver fat and visceral adiposity
Shelley E. Keating et al.
JOURNAL OF HEPATOLOGY (2015)
External Validation of Fatty Liver Index for Identifying Ultrasonographic Fatty Liver in a Large-Scale Cross-Sectional Study in Taiwan
Bi-Ling Yang et al.
PLOS ONE (2015)
Visceral Adiposity Index (VAI) Is Predictive of an Altered Adipokine Profile in Patients with Type 2 Diabetes
Marco C. Amato et al.
PLOS ONE (2014)
Visceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction
Marco Calogero Amato et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
A new index (CHOLINDEX) in detecting coronary artery disease risk
Onur Akpinar et al.
ANATOLIAN JOURNAL OF CARDIOLOGY (2013)
Role of Body Mass Index, Waist-to-Height and Waist-to-Hip Ratio in Prediction of Nonalcoholic Fatty Liver Disease
Rui-Dan Zheng et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2012)
Comparison of two methods using plasma triglyceride concentration as a surrogate estimate of insulin action in nondiabetic subjects: triglycerides x glucose versus triglyceride/high-density lipoprotein cholesterol
Fahim Abbasi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
A simple index of lipid overaccumulation is a good marker of liver steatosis
Giorgio Bedogni et al.
BMC GASTROENTEROLOGY (2010)
From the metabolic syndrome to NAFLD or vice versa?
Ester Vanni et al.
DIGESTIVE AND LIVER DISEASE (2010)
Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
Jeong-Hoon Lee et al.
DIGESTIVE AND LIVER DISEASE (2010)
Predictive performances of lipid accumulation product vs. adiposity measures for cardiovascular diseases and all-cause mortality, 8.6-year follow-up: Tehran lipid and glucose study
Mohammadreza Bozorgmanesh et al.
LIPIDS IN HEALTH AND DISEASE (2010)
Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study
Mohammadreza Bozorgmanesh et al.
LIPIDS IN HEALTH AND DISEASE (2010)
Aerobic Exercise Training Reduces Hepatic and Visceral Lipids in Obese Individuals Without Weight Loss
Nathan A. Johnson et al.
HEPATOLOGY (2009)
Share Paper
